Comparison of bone augmentation techniques in the mandibular posterior region: A randomized clinical trial protocol
- 1School of Dentistry, Universidad de Especialidades Espíritu Santo, Samborondón, Ecuador.
Abstract
This randomized, statistician-blinded, parallel-group clinical trial will compare the effectiveness of three bone-augmentation techniques applied to the posterior mandible using the cortical shell approach. Eighty-seven participants will be randomly allocated into three groups (autogenous, xenogeneic, or allogeneic cortical shells), each combined with a 1:1 mixture of autogenous bone chips and biomaterial. Participants may contribute one or two eligible posterior mandibular sites; however, the unit of analysis for the primary outcome will be the participant, using a participant-level summary (mean value when two sites are treated). The study is registered at ClinicalTrials.gov (Identifier: NCT06661447). Recruitment has not yet begun. The single primary endpoint is horizontal bone gain (mm) at 6 months, evaluated by cone-beam computed tomography (CBCT). Additional CBCT assessments at 3 and 12 months will be analyzed as secondary longitudinal outcomes. Volumetric and morphometric analyses will be performed through a standardized digital workflow integrating intraoral scanning, CBCT segmentation, and surface registration. Secondary outcomes will include bone density, surgical duration, and postoperative inflammation. Based on a previous CBCT-based randomized clinical trial with a related horizontal ridge-augmentation methodology, assuming a pooled standard deviation of approximately 1.12 mm and a clinically relevant between-group difference of 1.0 mm, 26 evaluable participants per group are required to achieve approximately 81.5% power for each prespecified primary comparison using a conservative two-sided α of 0.025 for sample-size planning. To allow for an anticipated 10% attrition rate, 29 participants will be recruited per group, resulting in a total planned sample of 87 participants. The primary analysis will use an ANCOVA model adjusted for baseline ridge width. This study aims to generate controlled, quantitative evidence on the volumetric and clinical performance of different cortical graft materials for posterior mandibular reconstruction. Trial registration ClinicalTrials.gov Identifier: NCT06661447. The registry record will be updated before recruitment begins.
Related
- Comparison of Techniques for Isolating Small Extracellular Vesicles from Drosophila Larval Hemolymph
- Long-Term Speech Outcomes After Primary Palatoplasty: A Comparison of Minimal-Incision Intravelar and Modified Veau–Wardill–Kilner Techniques
- Comparison of two repetitive peripheral magnetic stimulation protocols for upper trapezius myofascial pain syndrome: A randomized trial
- Playing by their own rules: clade-specific trends in mandibular form and function disrupt current paradigms of early tetrapod evolution
- Synergistic Variants in C-terminal Binding Protein 1 and Alkaline Phosphatase Lead to Mandibular Hypoplasia Through Impaired Wnt Signaling: An Oligogenic Model
BibTeX
@article{lanataflores2026comparison,
title = {{Comparison of bone augmentation techniques in the mandibular posterior region: A randomized clinical trial protocol}},
author = {Antonio Lanata-Flores and Marcelo Armijos Briones and Pablo Benítez Sellán and Patricia Estefanía Ayala Aguirre},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0337304},
url = {https://doi.org/10.1371/journal.pone.0337304},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparison of bone augmentation techniques in the mandibular posterior region: A randomized clinical trial protocol
AU - Antonio Lanata-Flores
AU - Marcelo Armijos Briones
AU - Pablo Benítez Sellán
AU - Patricia Estefanía Ayala Aguirre
PY - 2026
DA - 2026/10/29
JO - PLOS One
DO - 10.1371/journal.pone.0337304
UR - https://doi.org/10.1371/journal.pone.0337304
AB - This randomized, statistician-blinded, parallel-group clinical trial will compare the effectiveness of three bone-augmentation techniques applied to the posterior mandible using the cortical shell approach. Eighty-seven participants will be randomly allocated into three groups (autogenous, xenogeneic, or allogeneic cortical shells), each combined with a 1:1 mixture of autogenous bone chips and biomaterial. Participants may contribute one or two eligible posterior mandibular sites; however, the unit of analysis for the primary outcome will be the participant, using a participant-level summary (mean value when two sites are treated). The study is registered at ClinicalTrials.gov (Identifier: NCT06661447). Recruitment has not yet begun. The single primary endpoint is horizontal bone gain (mm) at 6 months, evaluated by cone-beam computed tomography (CBCT). Additional CBCT assessments at 3 and 12 months will be analyzed as secondary longitudinal outcomes. Volumetric and morphometric analyses will be performed through a standardized digital workflow integrating intraoral scanning, CBCT segmentation, and surface registration. Secondary outcomes will include bone density, surgical duration, and postoperative inflammation. Based on a previous CBCT-based randomized clinical trial with a related horizontal ridge-augmentation methodology, assuming a pooled standard deviation of approximately 1.12 mm and a clinically relevant between-group difference of 1.0 mm, 26 evaluable participants per group are required to achieve approximately 81.5% power for each prespecified primary comparison using a conservative two-sided α of 0.025 for sample-size planning. To allow for an anticipated 10% attrition rate, 29 participants will be recruited per group, resulting in a total planned sample of 87 participants. The primary analysis will use an ANCOVA model adjusted for baseline ridge width. This study aims to generate controlled, quantitative evidence on the volumetric and clinical performance of different cortical graft materials for posterior mandibular reconstruction. Trial registration ClinicalTrials.gov Identifier: NCT06661447. The registry record will be updated before recruitment begins.
SN - 1932-6203
ER -